Clinical Trial Record

Return to Clinical Trials

Pancreatic Cancer Registry: For Any Person With a Personal or Family History


1994-06


2030-06


2032-12


12000

Study Overview

Pancreatic Cancer Registry: For Any Person With a Personal or Family History

The NFPTR was established in 1994 to find the causes of pancreatic cancer. In brief, the investigators are interested in both the genetic and non-genetic causes of pancreatic cancer. The investigators are particularly interested in finding the genes that cause pancreatic cancer to cluster in some families. Up to 10% of pancreatic cancer patients have another close relative who has also developed pancreatic cancer. This clustering of pancreatic cancers in families has yet to be explained; however, the investigators continue to identify new familial pancreatic cancer genes that explain this clustering in subsets of families. For example, in 2009 and 2012 the investigators discovered that mutations in the PALB2 and ATM genes jointly account up to 5% of the clustering of pancreatic cancer in families.

N/A

  • Pancreatic Cancer, ATM, BRCA, Hereditary Cancer
    • NA_00035453
    • P50CA062924 (U.S. NIH Grant/Contract)

    Study Record Dates

    These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

    Study Registration Dates Results Reporting Dates Study Record Updates

    2016-08-29  

    N/A  

    2024-07-16  

    2016-08-31  

    N/A  

    2024-07-17  

    2016-09-01  

    N/A  

    2024-07  

    Study Plan

    This section provides details of the study plan, including how the study is designed and what the study is measuring.

    Design Details

    Primary Purpose:
    N/A


    Allocation:
    N/A


    Interventional Model:
    N/A


    Masking:
    N/A


    Arms and Interventions

    Participant Group/ArmIntervention/Treatment
    : participants

    individuals with a personal or family history of pancreas tumors

    Primary Outcome MeasuresMeasure DescriptionTime Frame
    pancreatic cancer35 years
    Secondary Outcome MeasuresMeasure DescriptionTime Frame

    Contacts and Locations

    This section provides the contact details for those conducting the study, and information on where this study is being conducted.

    Study Contact

    Name: Alison Klein, PhD, MHS

    Phone Number: 410-955-3502

    Email: pancreas@jhmi.edu

    Participation Criteria

    Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

    Ages Eligible for Study:
    ALL

    Sexes Eligible for Study:
    18 Years

    Accepts Healthy Volunteers:
    1

      Inclusion Criteria:

    • personal or family history of pancreas tumors

    • Exclusion Criteria:

    • none

    Collaborators and Investigators

    This is where you will find people and organizations involved with this study.

    • National Cancer Institute (NCI)

    • PRINCIPAL_INVESTIGATOR: Alison Klein, PhD, MHS, Johns Hopkins University

    Publications

    The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

    General Publications

    No publications available